-
2 weeks ago | 
kff.org | Lindsey Dawson |Jennifer Kates
On March 27th, the Trump administration announced that the U.S. Department of Health and Human Services (HHS) would implement “a dramatic restructuring” in accordance with President Trump’s Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.” This included plans to reduce the Department’s workforce by 10,000 employees.
-
2 months ago | 
healio.com | Sara Kellner |Carol L. DiBerardino |Jennifer Kates |Sten H Vermund
Key takeaways: An estimated 700,000 children receive HIV treatment each year through PEPFAR. The State Department issued a limited waiver to resume HIV services, but many clinics already let staff go. Millions of children in Africa rely on funding from the United States for HIV care or testing — support that was threatened last month when President Donald J. Trump froze foreign aid spending after taking office.
-
2 months ago | 
kff.org | Cynthia Cox |Matthew Rae |Jennifer Kates |Emma Wager
On Friday January 31, 2025, several federal government datasets went offline. The datasets taken down included some widely used, large-scale national health surveys, indices, and data dashboards that inform research, policy making, and media coverage about health care and public health.
-
Nov 22, 2024 | 
clinicaladvisor.com | Jennifer Kates |Josh Michaud
Federal officials have significant authority to influence and alter vaccine policy, which could affect vaccine availability, views about vaccines, and vaccine use in the US.
-
Nov 22, 2024 | 
clinicaladvisor.com | Jennifer Kates |Josh Michaud
KFF Health News — With President-elect Donald Trump announcing his intention to nominate Robert F. Kennedy, Jr, as Secretary of Health and Human Services (HHS), and several other nominations expected soon, including for the heads of the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), questions have been raised about what influence these appointed health officials have over US vaccine policy.
-
Nov 22, 2024 | 
clinicaladvisor.com | Jennifer Kates |Josh Michaud
Federal officials have significant authority to influence and alter vaccine policy, which could affect vaccine availability, views about vaccines, and vaccine use in the US.
-
Nov 20, 2024 | 
kff.org | Jennifer Kates |Josh Michaud
With President-elect Donald Trump announcing his intention to nominate Robert F. Kennedy, Jr. as Secretary of Health and Human Services (HHS), and several other nominations expected soon, including for the heads of the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), questions have been raised about what influence these appointed health officials have over U.S. vaccine policy.
-
Nov 1, 2024 | 
kff.org | Jennifer Kates
There is growing pressure on PEPFAR, the U.S. global HIV program, to increase its planning for sustainability, including through domestic resource mobilization and, ultimately, transitioning financing at least in part to recipient countries.1 While this is connected to a broader push in global health and development, driven by a constrained financing environment and desire to promote more country ownership of programs and services2, there are specific questions facing PEPFAR’s future.
-
Jun 18, 2024 | 
kff.org | Josh Michaud |Anna Rouw |Jennifer Kates
This brief was updated on June 18 to reflect developments at the 2024 World Health Assembly. In 2022, due to challenges and gaps exposed by the COVID-19 pandemic, member states of the World Health Organization (WHO) agreed to a process to review and potentially revise an existing international legal agreement known as the International Health Regulations (IHR).
-
May 21, 2024 | 
kff.org | Josh Michaud |Anna Rouw |Jennifer Kates
In 2022, due to challenges and gaps exposed by the COVID-19 pandemic, member states of the World Health Organization (WHO) agreed to a process to review and potentially revise an existing international legal agreement known as the International Health Regulations (IHR). This agreement outlines rights and responsibilities of WHO and governments, including the U.S., in handling international public health events and global health emergencies such as pandemics.
